Collagen supplementation in metabolic syndrome: a narrative review unraveling the biological mechanisms and effects Published online by Cambridge University Press: 22 December 2025 Abstract Collagen supplementation (CS) has emerged as a promising therapeutic approach with potential benefits for managing metabolic syndrome (MetS)-related risk factors
That means it is prohibited for tested athletes at all times, both in and out of competition, with no therapeutic-use exemption, and the ban is still in force on the 2026 list
Early clinical trials have shown promising results, with agents like semaglutide and exenatide demonstrating reductions in alcohol consumption and craving, as well as potential benefits for smoking cessation, such as reduced post-cessation weight gain
Avoid stacking if you have: Best for: Avoid if: Yes, theyre commonly stacked together under clinical guidance
Commonly studied areas include: Tendon and ligament models research looking at tendon-to-bone and soft-tissue repair processes